We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Omega Flex
OFLX
$305M
| $77K | ﹤0.01% |
2,314
-62
| -3% | -$2.1K |
|
|
BSF
3177
DELISTED
Bear State Financial, Inc.
BSF
| $77K | ﹤0.01% |
8,665
+73
| +0.8% | +$658 |
|
|
XCO
3178
DELISTED
Exco Resources
XCO
| $77K | ﹤0.01% |
6,831
-609
| -8% | -$6.72K |
|
|
REXI
3179
DELISTED
RESOURCE AMERICA INC CL-A
REXI
| $77K | ﹤0.01% |
11,623
-1,092
| -9% | -$8.32K |
|
|
UNIS
3180
DELISTED
Unilife Corporation
UNIS
| $76K | ﹤0.01% |
7,804
-6
| -0.1% | -$89 |
|
3181
Collegium Pharmaceutical
COLL
$1.15B
| $75K | ﹤0.01% |
3,407
+36
| +1% | +$651 |
|
|
GOGL
3182
DELISTED
Golden Ocean Group
GOGL
| $75K | ﹤0.01% |
6,134
-566
| -8% | -$9.68K |
|
3183
Ameresco
AMRC
$1.12B
| $74K | ﹤0.01% |
12,502
-2,505
| -17% | -$16K |
|
3184
Civeo
CVEO
$377M
| $74K | ﹤0.01% |
4,156
-1,767
| -30% | -$42K |
|
3185
Glaukos
GKOS
$8.92B
| $74K | ﹤0.01% |
+3,040
| New | +$91.5K |
|
3186
Willis Lease Finance
WLFC
$1.68B
| $74K | ﹤0.01% |
13,566
-942
| -6% | -$5.26K |
|
|
PAMT
3187
PAMT Corp
PAMT
$356M
| $74K | ﹤0.01% |
8,944
-724
| -7% | -$8.7K |
|
3188
Core Molding Technologies
CMT
$208M
| $73K | ﹤0.01% |
3,961
-1,030
| -21% | -$20.4K |
|
3189
LeMaitre Vascular
LMAT
$2.26B
| $73K | ﹤0.01% |
5,984
-6,010
| -50% | -$77.1K |
|
3190
Twin Disc
TWIN
$335M
| $73K | ﹤0.01% |
5,891
+474
| +9% | +$7.02K |
|
|
ACW
3191
DELISTED
Accuride Corp
ACW
| $73K | ﹤0.01% |
26,463
-1,925
| -7% | -$6.8K |
|
|
MCN
3192
Madison Covered Call & Equity Strategy Fund
MCN
$118M
| $72K | ﹤0.01% |
10,163
+1,833
| +22% | +$14K |
|
|
GNRT
3193
DELISTED
Gener8 Maritime, Inc.
GNRT
| $72K | ﹤0.01% |
+6,595
| New | +$86.1K |
|
|
CDI
3194
DELISTED
CDI Corp.
CDI
| $72K | ﹤0.01% |
8,379
-869
| -9% | -$9.23K |
|
|
ISRL
3195
DELISTED
Isramco Inc
ISRL
| $72K | ﹤0.01% |
722
-54
| -7% | -$6.94K |
|
|
RNWK
3196
DELISTED
RealNetworks Inc
RNWK
| $72K | ﹤0.01% |
17,568
| – | – |
|
3197
Enphase Energy
ENPH
$5.01B
| $71K | ﹤0.01% |
19,068
+1,543
| +9% | +$8.21K |
|
3198
Hingham Institution for Saving
HIFS
$613M
| $71K | ﹤0.01% |
614
+25
| +4% | +$2.88K |
|
|
MPX
3199
DELISTED
Marine Products Corp
MPX
| $71K | ﹤0.01% |
10,233
+2,113
| +26% | +$13.9K |
|
3200
Protara Therapeutics
TARA
$227M
| $71K | ﹤0.01% |
127
+13
| +11% | +$8.05K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.